Natixis Advisors, L.P. Insulet Corp Transaction History
Natixis Advisors, L.P.
- $51.3 Billion
- Q3 2024
A detailed history of Natixis Advisors, L.P. transactions in Insulet Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 33,161 shares of PODD stock, worth $8.73 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
33,161
Previous 24,607
34.76%
Holding current value
$8.73 Million
Previous $4.97 Million
55.42%
% of portfolio
0.02%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding PODD
# of Institutions
687Shares Held
62.6MCall Options Held
640KPut Options Held
881K-
Vanguard Group Inc Valley Forge, PA8.47MShares$2.23 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.77MShares$2.05 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.6 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.91MShares$768 Million0.03% of portfolio
-
Baillie Gifford & CO2.28MShares$599 Million0.4% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $18.3B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...